FAQ on New Therapeutic Developments in Relapsed/Refractory Multiple Myeloma

In this podcast episode, listen to myeloma experts Jesús F. San-Miguel, MD, PhD; Paula Rodriguez-Otero, MD, PhD; and Prof. Dr. med. Katja Weisel answer audience questions from a live CCO Webinar on available and emerging therapeutic strategies for patients with early and late relapsed/refractory multiple myeloma.